Tilray Brands reports record Q1 revenue of $257 million

Tilray Brands reported record net revenue of $257 million for its first fiscal quarter of 2027, representing a 23% increase year-over-year. The company saw significant growth in its international business, particularly in the EMEA region, where revenue rose by 71% driven by medical cannabis, beverages, and pharmaceutical distribution.

Its global beverage business, which includes BrewDog, generated $101 million in revenue with a gross margin of 41%. BrewDog reported strong retail momentum and expanded its distribution points in the UK. Tilray also reduced its outstanding debt by $42 million and reaffirmed its fiscal 2027 adjusted EBITDA guidance of $68 million to $75 million.